An International Phase 3 Randomized Trial of Autologus D

  • Gupta, Shilpa (PI)
  • Jha, Gautam (Prior Principal Investigator)

Project: Research project

Project Details

Description

An International Phase 3 Randomized Trial of Autologus Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
StatusFinished
Effective start/end date11/1/1211/30/18

Funding

  • Argos Therapeutics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.